Skip to main content
. 2022 Jan 21;17(1):118–122. doi: 10.18502/jovr.v17i1.10176

Table 2.

Clinical presentation and treatment


Clinical presentation Unilateral 89% (n = 38)
Palpebral edema 88% (n = 38)
Conjunctival congestion 81% (n = 35)
Chemosis 79% (n = 34)
Ocular pain 77% (n = 33)
Motility impairment 65% (n = 28)
Proptosis 56% (n = 24)
Blurred vision 39% (n = 17)
Complications AION 2.32% (n = 1)
Type of treatment Systemic corticoid 72% (n = 31)
Oral Prednisolone alone 48.83% (n = 21)
Methylprednisolone EV + Oral Prednisolone 23.25% (n = 10)
Solve spontaneously 11.63% (n = 5)
Without data 9.30 (n = 4)
NSAIDs 4.65 % (n = 2)
Topic Prednisolone 2.23% (n = 1)
AION, anterior ischemic optic neuritis; NSAIDs, nonsteroids anti-inflammatory drugs